Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

263
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
263
Seizures: Classification01:13

Seizures: Classification

304
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
304
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

178
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
178

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

People with epilepsy and intellectual disability.

Acta neurologica Belgica·2025
Same author

Seizure-related complication rate in a residential population with epilepsy and intellectual disability (ECOMRAID-trial).

Epilepsy & behavior : E&B·2023
Same author

Assessment of Trabecular Bone Score: a 7-year follow-up study in institutionalized adults with refractory epilepsy and intellectual disability.

Seizure·2022
Same author

Bone mineral density and fractures in institutionalised children with epilepsy and intellectual disability.

Journal of intellectual disability research : JIDR·2021
Same author

Incidence of clinical fractures: A 7-year follow-up study in institutionalized adults with epilepsy and intellectual disability.

Seizure·2021
Same author

Quantitative ultrasound for monitoring bone status in institutionalized adults with refractory epilepsy and intellectual disability: A 7-year follow-up study.

Seizure·2019

Related Experiment Video

Updated: Jun 11, 2025

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.3K

Update review on SUDEP: Risk assessment, background & seizure detection devices.

C P J A Monté1, J B A M Arends2, R H C Lazeron3

  • 1Academic Center for Epileptology Kempenhaeghe, Heeze, The Netherlands; Private Practice of Neurology, Zottegem, Belgium.

Epilepsy & Behavior : E&B
|October 9, 2024
PubMed
Summary
This summary is machine-generated.

Sudden unexpected death in epilepsy (SUDEP) is linked to generalized tonic-clonic seizures (GTC). Risk scores and seizure detection devices (SDDs) may aid prevention, though further validation is needed.

Keywords:
SUDEPSUDEP risk factorsSUDEP risk scoring systemsgeneralized tonic-clonic seizuresmechanisms of SUDEPseizure detection devices

More Related Videos

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.1K
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

5.9K

Related Experiment Videos

Last Updated: Jun 11, 2025

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.3K
Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note
05:54

Stereo-Electro-Encephalo-Graphy SEEG With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

17.1K
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
10:25

Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits

Published on: March 27, 2021

5.9K

Area of Science:

  • Neurology
  • Epileptology
  • Medical Device Technology

Background:

  • Sudden Unexpected Death in Epilepsy (SUDEP) remains a critical concern in epilepsy patient care.
  • Generalized tonic-clonic seizures (GTC) are identified as a primary risk factor for SUDEP.
  • Existing SUDEP risk stratification tools, including scoring systems, require further validation in general epilepsy populations.

Purpose of the Study:

  • To review current knowledge on SUDEP, focusing on risk factors, scoring systems, proposed mechanisms, and seizure detection devices (SDDs).
  • To evaluate the utility of SUDEP risk stratification and the potential of SDDs in SUDEP prevention strategies.
  • To discuss hypotheses regarding the underlying mechanisms of SUDEP.

Main Methods:

  • Literature review of SUDEP risk factors, scoring systems (SUDEP-7, SUDEP-3, SUDEP-CARE, Kempenhaeghe), proposed mechanisms, and validated seizure detection devices (SDDs).
  • Analysis of epidemiological data linking GTC frequency to SUDEP risk.
  • Evaluation of validation status and performance metrics for selected SDDs.

Main Results:

  • Generalized tonic-clonic seizures (GTC) are strongly associated with SUDEP, with high odds ratios reported.
  • Four SUDEP risk scoring systems exist, with three validated to varying degrees, but none are sufficiently validated for broad clinical use.
  • Five SDDs (Seizure Link®, Epi-Care®, NightWatch, Empatica, Nelli®) show high sensitivity (>90%) for detecting tonic-clonic seizures (TC), though direct SUDEP prevention is unproven.

Conclusions:

  • While GTC frequency is a key SUDEP risk factor and SDDs show promise for nocturnal supervision, robust validation for SUDEP prevention is still needed.
  • Current SUDEP risk scoring systems offer a framework but lack universal validation.
  • Further research into SUDEP mechanisms and the clinical utility of SDDs is essential for improving patient outcomes.